Company news
Climb Bio, Inc. (NASDAQ:CLYM) news
Every Climb Bio, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Climb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 6, 2026
Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Cong...
June 11, 2026
Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 20...
June 5, 2026
Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026
May 26, 2026
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
May 14, 2026
Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
May 7, 2026
Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportun...
May 5, 2026
Climb Bio, Inc. Announces $110.0 Million Private Placement
April 28, 2026
Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026
April 8, 2026
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
April 7, 2026
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 5, 2026
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 5, 2026
Climb Bio to Present at Upcoming Investor Conferences
February 5, 2026
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
January 8, 2026
Climb Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)
November 26, 2025
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 25, 2025
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 6, 2025
Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy
October 21, 2025
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
October 17, 2025
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer
October 1, 2025
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN
September 29, 2025
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
September 4, 2025
UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences
August 25, 2025
Climb Bio to Present at Upcoming September 2025 Investor Conferences
August 25, 2025
eGenesis Appoints Douglas Williams, Ph.D., and Adam Craig, M.D., Ph.D., to its Board of Directors
August 19, 2025
Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 12, 2025
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
June 18, 2025
Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
May 14, 2025
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
April 1, 2025
Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference
March 27, 2025
Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates
March 25, 2025
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
February 24, 2025
Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Neph...
January 9, 2025
Climb Bio to be Added to the Nasdaq Biotechnology Index
December 19, 2024
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
November 12, 2024
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
November 11, 2024
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
October 11, 2024